What is Spinal Muscular Atrophy

Spinal Muscular Atrophy (SMA) is a genetic condition that causes the progressive loss of motor neurons, leading to muscle weakness and atrophy throughout the body. It primarily affects the voluntary muscles used for activities like crawling, walking, head control, and swallowing, with severity varying significantly based on the age of onset and genetic factors.

What exactly is Spinal Muscular Atrophy?

Spinal Muscular Atrophy is a neuromuscular disorder characterized by the degeneration of motor neurons in the spinal cord and brainstem. These specialized nerve cells are responsible for sending signals from the brain to the muscles; when they are damaged, the muscles do not receive the necessary instructions to move, causing them to weaken and shrink (atrophy). With 972 individuals currently sharing their experiences on DiseaseMaps.org, it is clear that while the condition is rare, the community impact is significant and widespread.

What causes Spinal Muscular Atrophy?

The root cause of Spinal Muscular Atrophy is a mutation in the SMN1 (Survival Motor Neuron 1) gene. This gene is responsible for producing the SMN protein, which is essential for the health and survival of motor neurons. Without enough of this protein, the motor neurons perish, leading to the clinical symptoms of the disease. Spinal Muscular Atrophy is typically inherited in an autosomal recessive pattern, meaning a child must inherit one faulty gene copy from each parent to be affected.

How are the different types of Spinal Muscular Atrophy classified?

Clinicians generally classify Spinal Muscular Atrophy based on the age of symptom onset and the highest motor milestones achieved. While these categories provide a framework for care, the spectrum of the disease is broad:

• Type 1 (Werdnig-Hoffmann disease): Usually presents within the first six months of life; infants typically cannot sit without support.


• Type 2 (Dubowitz disease): Onset occurs between 6 and 18 months; individuals can usually sit but cannot stand or walk independently.


• Type 3 (Kugelberg-Welander disease): Onset occurs in early childhood or adolescence; individuals can walk but may experience progressive difficulties over time.


• Type 4: Adult-onset, typically characterized by mild to moderate muscle weakness that develops after the age of 21.

How common is this condition?

Spinal Muscular Atrophy is one of the most common genetic causes of infant mortality. The incidence is estimated to be approximately 1 in every 6,000 to 10,000 live births worldwide. Because it is an autosomal recessive condition, it affects males and females equally, and there is no significant difference in prevalence across different geographic or ethnic populations.

How does it differ from other neuromuscular diseases?

Unlike muscular dystrophies, which primarily affect the muscle tissue itself, Spinal Muscular Atrophy is fundamentally a disease of the nerves that control those muscles. This distinction is vital for diagnosis and treatment, as current therapies for Spinal Muscular Atrophy focus on increasing the production of the SMN protein to protect and preserve existing motor neurons.

Next steps

• Consult with a pediatric or adult neurologist specializing in neuromuscular disorders for a definitive genetic diagnosis.


• Connect with the community of 972 members on DiseaseMaps.org to share experiences and learn from others living with the condition.


• Reach out to organizations like Cure SMA to access patient support resources and information on the latest clinical trials.


• Seek genetic counseling to understand carrier status and family planning options.

Medical disclaimer: This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Spinal Muscular Atrophy


• Orphanet: Spinal Muscular Atrophy, proximal


• OMIM (Online Mendelian Inheritance in Man): Spinal Muscular Atrophy, Type I


• Cure SMA: Understanding SMA and Treatment Options